Likewise, the levels of circulating tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and IL-6 in both patients and mice with NAFLD were significantly higher than those in controls (Tables S1, S2, P < 0.001). The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.